NEW YORK (GenomeWeb News) – Abbott today reported its molecular diagnostics business rose 1 percent year over year during the second quarter while total sales grew 2 percent.

For the three months ended June 30, molecular diagnostics sales increased to $106 million, compared to $105 million a year ago. In the US, molecular diagnostics rose 7.3 percent year over year to $48 million, while internationally, the business dropped 3.8 percent to $58 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Dec
11
Sponsored by
PerkinElmer

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.